Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
18,984
Total Claims
$1.3M
Drug Cost
643
Beneficiaries
$1,953
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-96%
Opioid rate vs peers
0.1% vs 2.2% avg
+38%
Cost per patient vs peers
$1,953 vs $1,411 avg
+53%
Brand preference vs peers
16.3% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
17
Opioid Claims
$350
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 3,091 claims · $893K
Generic: 15,856 claims · $360K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 503 | $190K |
| Dulaglutide | 69 | $54K |
| Insulin Detemir | 290 | $52K |
| Rifaximin | 34 | $44K |
| Empagliflozin | 74 | $34K |
| Insulin Aspart | 122 | $34K |
| Insulin Detemir | 57 | $32K |
| Risperidone Microspheres | 24 | $30K |
| Linaclotide | 54 | $30K |
| Rivaroxaban | 76 | $23K |
| Sevelamer Carbonate | 33 | $23K |
| Fluticasone Propion/Salmeterol | 50 | $21K |
| Linagliptin | 76 | $20K |
| Umeclidinium Brm/Vilanterol Tr | 36 | $17K |
| Sacubitril/Valsartan | 53 | $17K |
Prescribing Profile
Patient Profile
78
Avg Age
61%
Female
3.01
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data